Liang Chen

Liang Chen

Auto-generated profile, based on publicly available information

Liang Chen

Biomedical Engineering, Wayne State University, Detroit, MI, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2019 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
PDF file
LCLiang Chen
Liang Chen
HMHanan Mazeh
Hanan Mazeh
AGAngelica Guardia
Angelica Guardia
WSWei Song
Wei Song
PBPaul Begeman
Paul Begeman
WRWeiping Ren
Weiping Ren
Electrospun nanofibers mimic the bone’s extra-cellular matrix and represent an alternative implant coating to enhance implant osseointegration. Approximately 99% of the strontium (Sr2+) in our body deposits in the bone and serves as a stimulator of bone formation. The purpose of this study was to develop an Sr2+-doped coaxial polycaprolactone (PCL)/poly(D,L-lactide-co-glycolide) (PLGA)-polyvinyl alcohol (PVA) nanofiber coating to enhance the osseointegration. An optimized PCL/PLGA (1:1 v/v) sheath fiber formula was identified to match the nanofibers degradation to the implant osseointegration physiology. Scanning electron microscopy images showed that the Sr2+-doped nanofibers had a less dense structure and larger porosity than the nanofibers without Sr2+ doping. A sustained Sr2+ release from the PCL/PLGA-PVA coaxial nanofibers was observed for over two months. The indirect and direct cellular contact studies confirmed the biocompatibility of the Sr2+-doped PCL/PLGA-PVA coaxial nanofibers. The Sr2+-doped nanofibers provided further and significant enhancement of the differentiation of murine pre-osteoblast MC3T3-E1 cells. These findings indicate that Sr2+-doped PCL/PLGA-PVA coaxial nanofibers have a great potential to be applied as a new implant coating matrices.

27 May 2022 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
WRWeiping Ren
Weiping Ren
XYXiaowei Yu
Xiaowei Yu
LCLiang Chen
Liang Chen
TSTong Shi
Tong Shi
TBTherese Bou-Akl
Therese Bou-Akl
DMDavid C Markel
David C Markel
Prosthesis with antibiotic-eluting nanofibrous (NF) coating represents coating alternative to prevent periprosthetic joint infection (PJI). In this study, four formulas of erythromycin (EM)-embedded both in core and sheath components of coaxial PCL/PLGA-PVA NF coatings were developed: EM 0 (no EM), EM 100 (100 μg/mL), EM500 (500 μg/mL) and EM1000 (1000 μg/mL). EM doping altered the physicochemical and structural properties of NFs to some extent, including the increase of NF porosity and surface wettability. A sustained EM release from EM-NFs for >4 weeks was observed. Eluents collected from EM-NFs showed strong zone of inhibition (ZOI) to Staphylococcus aureus growth and the sizes of ZOI positively related to the amount of EM released. EM-NFs were nontoxic to rat bone marrow stem cells (rBMSCs). Cell growth was significantly enhanced when comparing rBMSCs cultured on EM-NFs (EM0 and EM 100) to those cultured on NF-free control. Cell differentiation (ALP activity) was notably enhanced by EM100, compared to control and EM0. Eluents from EM-NFs on rBMSCs were also investigated. The presence of 10% EM-NF eluents inhibited the growth of rBMSCs, which was proportional to the amount of EM doped. The ALP activity was notably enhanced by eluents from EM-NFs with the highest activity in EM100 compared to control and EM0. Our data indicate that EM-doped PCL/PLGA-PVA coaxial NF coatings have a great potential to be applied as a new implant coating matrices. Further in vivo testing in animal models is currently planned that should represent the first step in predicting the clinical outcomes of EM-eluting NF coating approach.